Recently, the team of Xi Tan has reported that ECD inhibits the growth of laryngeal carcinoma via the STAT3/Cyclin D1 pathway and it was the first study on the mechanism of ECD in the treatment of tumors (Tan et al., 2020). This evidence concerns the gene STAT3 and laryngeal carcinoma.